v3.19.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenues:        
Total Revenues $ 41,662 $ 31,243 $ 156,090
Selling, general and administrative expenses 1,157,064 1,104,713 3,989,274 5,266,444
Research and development expenses 676,970 424,596 1,418,293 945,508
Loss from Operations (1,834,034) (1,487,647) (5,376,324) (6,055,862)
Other (Income) Expense:        
Amortization of debt discount (12,500) 6,562,736
Gain on extinguishment of convertible notes payable (1,481,317)
Interest (income) expense, net (19,139) (6,981) (41,680) 315,441
Change in fair value of derivative liabilities (191,656)
Total Other (Income) Expense (19,139) (19,481) (41,680) 5,205,204
Net Loss (1,814,895) (1,468,166) (5,334,644) (11,261,066)
Deemed dividend to preferred stockholders (3,310,001)
Net Loss Attributable to Common Stockholders $ (1,814,895) $ (1,468,166) $ (5,334,644) $ (14,571,067)
Net Loss Per Basic and Diluted Common Share: $ (0.10) $ (0.13) $ (0.35) $ (1.70)
Weighted Average Number of Common Shares Outstanding: Basic and Diluted 17,922,129 11,717,307 15,029,969 8,568,275
Royalty Income [Member]        
Revenues:        
Total Revenues $ 28,062 $ 31,243 $ 88,090
Contract Research - Related Party [Member]        
Revenues:        
Total Revenues $ 13,600 $ 68,000

Source